PKCδ

PKCδ (protein kinase C delta, PRKCD) is a member of the novel protein kinase C family and functions as a calcium-independent, diacylglycerol-responsive serine/threonine kinase that regulates cellular signaling, apoptosis, differentiation, and stress responses^[1][2]. Mechanistically, PKCδ is activated through distinct phosphorylation-dependent and tyrosine phosphorylation-dependent mechanisms, enabling its participation in oxidative stress signaling, receptor-mediated pathways, and downstream regulation of cell fate decisions^[3][4][5]. PKCδ has emerged as a critical regulator of apoptotic processes, and proteomic as well as functional studies identify it as a major mediator of cell death signaling in multiple physiological and pathological contexts^[6][7]. In disease models, PKCδ contributes to neuronal apoptosis in Parkinson’s disease models, vascular smooth muscle cell apoptosis after arterial injury, and inflammatory signaling associated with sepsis and cardiovascular disorders^{[7][8][9][10]}. Compared with related PKC isoforms, PKCδ displays distinctive activation mechanisms and biological functions that are strongly influenced by site-specific tyrosine phosphorylation and subcellular localization, supporting non-redundant signaling roles within the PKC family^[3][4][5]. For experimental applications, pharmacological inhibition of PKCδ has been widely used to investigate apoptosis-associated pathways, although the selectivity of the commonly used compound rottlerin remains controversial and requires careful interpretation of experimental results^[7][11].